Evidence
Int Immunopharmacol. 2024 Jul 18:112649. doi: 10.1016/j.intimp.2024.112649. Online ahead of print.
NO ABSTRACT
PMID:39030079 | DOI:10.1016/j.intimp.2024.112649
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Corrigendum to “Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling” [Int. Immunopharmacol. 113 (2022) 109421]
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
![Corrigendum to "Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling" [Int. Immunopharmacol. 113 (2022) 109421]](https://psychiatryai.com/wp-content/uploads/2021/11/android-chrome-512x512-2.png "Corrigendum to \"Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling\" [Int. Immunopharmacol. 113 (2022) 109421]")
Evidence Blueprint
Corrigendum to “Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling” [Int. Immunopharmacol. 113 (2022) 109421]
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Corrigendum to “Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling” [Int. Immunopharmacol. 113 (2022) 109421]
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
